Aequus Pharmaceuticals Inc. (CVE:AQS – Get Free Report) shares hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as C$0.01 and last traded at C$0.01, with a volume of 10000 shares. The stock had previously closed at C$0.01.
Aequus Pharmaceuticals Price Performance
The stock’s fifty day moving average price is C$0.01 and its 200-day moving average price is C$0.02. The firm has a market cap of C$1.33 million, a PE ratio of -1.00 and a beta of -0.02. The company has a debt-to-equity ratio of 138.88, a current ratio of 0.07 and a quick ratio of 0.46.
About Aequus Pharmaceuticals
Aequus Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease.
Featured Stories
- Five stocks we like better than Aequus Pharmaceuticals
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- How to Calculate Return on Investment (ROI)
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Aequus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aequus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
